Tianjin Zhongxin Pharmaceutical Group announced earnings of RMB198.9 million ($41.8 million) in 3Q2021, up 30% from the previous corresponding period. 

In 9M2021, net attributable profit stood at RMB661.5 million, a 39% increase y-o-y, mainly due to an increase in sales. 

See: Tianjin Zhongxin posts 12% rise in 1Q earnings to $27 mil

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook